Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for Akebia Therapeutics, Inc. (AKBA)

« Back to company index

AKBA Chatter Timeline

Stock Ticker for AKBA

Most Active Tweeters for AKBA

No tweets found

Recent Tweets for AKBA

beyond_ninety @beyond_ninety
Bkd Wealth Advisors Raised Its Lakeland Finl $LKFN Stake; Perceptive Advisors Upped Akebia Therapeutics $AKBA Holdi… https://t.co/TWxJMDo0Te
August 20th 2018, 7:08am
OlympiaReport @OlympiaReport
Akebia Therapeutics Inc $AKBA Receives $21.50 Consensus PT from Brokerages https://t.co/Cr6euV5BNh
August 19th 2018, 4:08pm
MareaInformativ @MareaInformativ
Akebia Therapeutics Inc $AKBA Receives Consensus Rating of “Buy” from Brokerages https://t.co/22L8ZzFk13
August 19th 2018, 4:08pm
TranscriptDaily @TranscriptDaily
Akebia Therapeutics $AKBA Raised to Buy at Zacks Investment Research https://t.co/NrzkJSOdwL
August 19th 2018, 5:08am
1MinuteStock @1MinuteStock
Wondering about risks of $AKBA? The 21-day volatility is 17.87% https://t.co/PGIz4jyyqQ
August 19th 2018, 5:08am
1MinuteStock @1MinuteStock
We calculated 21-day Expected Return of $AKBA for you: -24.1% https://t.co/3YF6WoRJbF
August 19th 2018, 4:08am
OlympiaReport @OlympiaReport
Akebia Therapeutics $AKBA Upgraded by Zacks Investment Research to Buy https://t.co/zYcei5imWm
August 18th 2018, 2:08pm
dispatchtribune @dispatchtribune
Akebia Therapeutics $AKBA Raised to Buy at Zacks Investment Research https://t.co/POzFp4rBdZ
August 18th 2018, 2:08pm
MareaInformativ @MareaInformativ
Akebia Therapeutics $AKBA Price Target Cut to $18.00 by Analysts at Needham & Company LLC https://t.co/aOR3XqksSi
August 17th 2018, 9:08am
bbnsnews @bbnsnews
Akebia Therapeutics $AKBA Upgraded to Buy by Zacks Investment Research https://t.co/jMAMQOqMZO
August 17th 2018, 8:08am
bbnsnews @bbnsnews
Akebia Therapeutics $AKBA Now Covered by Analysts at Raymond James https://t.co/4tyhPXRrJx
August 17th 2018, 6:08am
a3igner @a3igner
TradeFlags : TD BUY $AKBA at 7.88, Supp 7.59 Resis 10.49 R38 HiLo 4% T1Y 21 buy 2.0 fwdPE -4.3 DIV N/A #Akebia The… https://t.co/GiwqUyp7IL
August 16th 2018, 11:08pm
TradeFlags @TradeFlags
TD BUY $AKBA at 7.88, Supp 7.59 Resis 10.49 R38 HiLo 4% T1Y 21 buy 2.0 fwdPE -4.3 DIV N/A #Akebia The #stocks… https://t.co/S1FqIR8lY7
August 16th 2018, 11:08pm
TranscriptDaily @TranscriptDaily
-$0.77 EPS Expected for Akebia Therapeutics Inc $AKBA This Quarter https://t.co/j4WhqEqQaT
August 16th 2018, 5:08pm
dispatchtribune @dispatchtribune
Akebia Therapeutics Inc $AKBA Expected to Announce Quarterly Sales of $39.71 Million https://t.co/skaoLcwKPz
August 16th 2018, 5:08pm
registrarjourn @registrarjourn
Zacks: Brokerages Expect Akebia Therapeutics Inc $AKBA Will Announce Quarterly Sales of $39.71 Million https://t.co/lk1dnU92Q4
August 16th 2018, 5:08pm
EnterpriseLeade @EnterpriseLeade
Zacks: Brokerages Expect Akebia Therapeutics Inc $AKBA Will Announce Quarterly Sales of $39.71 Million https://t.co/pW0kxOW2k4
August 16th 2018, 5:08pm
ZolmaxNews @ZolmaxNews
Akebia Therapeutics $AKBA Upgraded to Buy by Zacks Investment Research https://t.co/1lV1VNjep9
August 16th 2018, 12:08pm
MareaInformativ @MareaInformativ
Akebia Therapeutics $AKBA Upgraded to Buy by Zacks Investment Research https://t.co/w54mZ16PDV
August 16th 2018, 12:08pm
NextGenStock @NextGenStock
$AKBA added. Focuses on dev and comm of novel therapies for patients with renal disease through hypoxia-inducible f… https://t.co/hz1AKT1VmQ
August 16th 2018, 8:08am
dakotafinancial @dakotafinancial
Akebia Therapeutics $AKBA Earns Buy Rating from Analysts at Raymond James https://t.co/JHfBLgWDVN
August 16th 2018, 4:08am
WeekHerald @WeekHerald
Zacks Investment Research Upgrades Akebia Therapeutics $AKBA to Buy https://t.co/RTtsvBlkiB
August 15th 2018, 5:08pm
ThisLincolnian @ThisLincolnian
Zacks Investment Research Upgrades Akebia Therapeutics $AKBA to Buy https://t.co/dB9MeSynKu
August 15th 2018, 5:08pm
beyond_ninety @beyond_ninety
Nantahala Capital Management Has Upped Akebia Therapeutics $AKBA Holding; Two Harbors Investment Has 0.25 Sentiment https://t.co/l7KhgSNuk1
August 15th 2018, 3:08pm
bbnsnews @bbnsnews
Q3 2018 Earnings Forecast for Akebia Therapeutics Inc Issued By Piper Jaffray Companies $AKBA https://t.co/pWcDNov44S
August 15th 2018, 8:08am
beyond_ninety @beyond_ninety
Roundview Capital Lowered Its Holding in Ross Stores $ROST as Stock Declined; Akebia Therapeutics $AKBA Market Valu… https://t.co/Vq4f4pIraT
August 15th 2018, 5:08am
TickerReport @TickerReport
Akebia Therapeutics $AKBA Now Covered by Raymond James https://t.co/t1TTYy1qth
August 15th 2018, 5:08am
dailypoliticaln @dailypoliticaln
Akebia Therapeutics $AKBA Now Covered by Raymond James https://t.co/Vk7qRBSfwh
August 15th 2018, 5:08am
dakotafinancial @dakotafinancial
Akebia Therapeutics $AKBA Hits New 52-Week Low Following Analyst Downgrade https://t.co/Xn5XU7dSt2
August 15th 2018, 1:08am
bibeypost_stock @bibeypost_stock
Will New Ratings Coverage by Raymond James Help Akebia Therapeutics $AKBA Stock This Week? - https://t.co/7esPwiZ3Bm
August 14th 2018, 6:08pm
reurope_stock @reurope_stock
Akebia Therapeutics $AKBA Hit With Outperform Rating From Raymond James, Analysts Expect $18 Stock Price https://t.co/1XqDwHHu1X
August 14th 2018, 6:08pm
The_CasualSmart @The_CasualSmart
It is Time to "Outperform" Akebia Therapeutics $AKBA, Raymond James Says. Stock May Be Worth $18 https://t.co/J862uCYikU
August 14th 2018, 6:08pm
mmahotstuff1 @mmahotstuff1
Raymond James Says Its Time To Outperform Akebia Therapeutics $AKBA. Will Stock Hit Their Target of $18? - https://t.co/5LKgsiZaEa
August 14th 2018, 6:08pm
whatsonthorold2 @whatsonthorold2
Akebia Therapeutics $AKBA Moves On Raymond James Initiation. How Much Are Shares Worth? - https://t.co/BbnSCOeYWj
August 14th 2018, 6:08pm
west_moreland @west_moreland
Will New Ratings Coverage by Raymond James Help Akebia Therapeutics $AKBA Stock This Week? https://t.co/tfVYjfEfNO
August 14th 2018, 6:08pm
The_CasualSmart @The_CasualSmart
Will New Ratings Coverage by Raymond James Help Akebia Therapeutics $AKBA Stock This Week? https://t.co/sXMoaIw7GF
August 14th 2018, 6:08pm
Fanob_stock @Fanob_stock
Akebia Therapeutics $AKBA Hit With Outperform Rating From Raymond James, Analysts Expect $18 Stock Price https://t.co/omB29ByWGv
August 14th 2018, 6:08pm
WeekHerald @WeekHerald
Akebia Therapeutics Inc $AKBA Expected to Post Earnings of -$0.64 Per Share https://t.co/nowwkMtNoO
August 14th 2018, 1:08pm
TranscriptDaily @TranscriptDaily
Akebia Therapeutics Inc $AKBA Given Average Rating of “Buy” by Analysts https://t.co/viDs7m1sLU
August 14th 2018, 1:08pm
AmericanBanking @AmericanBanking
Akebia Therapeutics Inc $AKBA Given Average Rating of “Buy” by Analysts https://t.co/XVblFSWNix #stocks
August 14th 2018, 1:08pm
ThisLincolnian @ThisLincolnian
Analysts Anticipate Akebia Therapeutics Inc $AKBA Will Post Earnings of -$0.64 Per Share https://t.co/7s4EbWivfx
August 14th 2018, 1:08pm
TheMarketsDaily @TheMarketsDaily
Akebia Therapeutics $AKBA Coverage Initiated at Raymond James https://t.co/gbgkTOzBFi
August 14th 2018, 1:08pm
AlertTrade @AlertTrade
SOCIAL ACTIVITY: $AKBA - AKEBIA THERAPEUTICS ? TradeIdeas via ? https://t.co/VS8RO1bzXJ
August 14th 2018, 9:08am
BioStocks @BioStocks
$AKBA initiated at Outperform at Raymond James
August 14th 2018, 6:08am
WeekHerald @WeekHerald
Needham & Company LLC Lowers Akebia Therapeutics $AKBA Price Target to $18.00 https://t.co/bQZIEdKyEE
August 14th 2018, 5:08am
ThisLincolnian @ThisLincolnian
Needham & Company LLC Lowers Akebia Therapeutics $AKBA Price Target to $18.00 https://t.co/KsnoWJKqy6
August 14th 2018, 5:08am
The_CasualSmart @The_CasualSmart
Bremer Trust National Association Trimmed Ipg Photonics $IPGP Stake; Akebia Therapeutics $AKBA SI Decreased By 0.36% https://t.co/1iVNm8DK6w
August 14th 2018, 5:08am
ConsumerFeed @ConsumerFeed
Akebia Therapeutics Inc Expected to Post Q3 2018 Earnings of -$0.67 Per Share $AKBA https://t.co/Hq5jUoj0nU
August 14th 2018, 4:08am
WeekHerald @WeekHerald
Akebia Therapeutics $AKBA Reaches New 1-Year Low Following Analyst Downgrade https://t.co/5PivKLJQzb
August 14th 2018, 1:08am
ThisLincolnian @ThisLincolnian
Akebia Therapeutics $AKBA Reaches New 12-Month Low Following Analyst Downgrade https://t.co/MRTMUMltd0
August 14th 2018, 1:08am

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2018. All rights reserved.